OBJECTIVE: To evaluate the influence of ethnicity on the use of peritoneal dialysis (PD) as initial treatment for end-stage renal disease (ESRD) after controlling for other patient characteristics. DESIGN: Inception cohort analysis of incident ESRD patients. PATIENTS: All African-American and white patients (N = 10,726) who began treatment for ESRD at dialysis centers in North Carolina, South Carolina, and Georgia and reported to ESRD Network 6 between January 1, 1989, and December 31, 1991. MAIN OUTCOME MEASURE: Odds ratios (ORs) of the association between ethnicity and PD as initial treatment modality. RESULTS: African-American patients were 56% less likely than whites to use PD (OR, 0.44; 95% confidence interval [CI], 0.40 to 0.49). This difference persisted (OR, 0.45; 95% CI, 0.38 to 0.52) after multivariable adjustment for age, education, social support, home ownership, functional status, albumin level, hypertension, history of myocardial infarction, peripheral neuropathy, and comorbid diabetes. CONCLUSIONS: Ethnic differences in initial PD use cannot be explained by many demographic, socioeconomic, and comorbid factors associated with the use of PD as initial treatment for ESRD.
OBJECTIVE: To evaluate the influence of ethnicity on the use of peritoneal dialysis (PD) as initial treatment for end-stage renal disease (ESRD) after controlling for other patient characteristics. DESIGN: Inception cohort analysis of incident ESRDpatients. PATIENTS: All African-American and white patients (N = 10,726) who began treatment for ESRD at dialysis centers in North Carolina, South Carolina, and Georgia and reported to ESRD Network 6 between January 1, 1989, and December 31, 1991. MAIN OUTCOME MEASURE: Odds ratios (ORs) of the association between ethnicity and PD as initial treatment modality. RESULTS: African-American patients were 56% less likely than whites to use PD (OR, 0.44; 95% confidence interval [CI], 0.40 to 0.49). This difference persisted (OR, 0.45; 95% CI, 0.38 to 0.52) after multivariable adjustment for age, education, social support, home ownership, functional status, albumin level, hypertension, history of myocardial infarction, peripheral neuropathy, and comorbid diabetes. CONCLUSIONS: Ethnic differences in initial PD use cannot be explained by many demographic, socioeconomic, and comorbid factors associated with the use of PD as initial treatment for ESRD.
Authors: Suma Prakash; Rudolph A Rodriguez; Peter C Austin; Refik Saskin; Alicia Fernandez; Louise M Moist; Ann M O'Hare Journal: J Am Soc Nephrol Date: 2010-06-17 Impact factor: 10.121
Authors: Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers Journal: J Am Soc Nephrol Date: 2016-05-13 Impact factor: 10.121
Authors: Marc Turenne; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Elizabeth Cope Journal: Health Serv Res Date: 2017-05-30 Impact factor: 3.402
Authors: Amar A Desai; Roger Bolus; Allen Nissenson; Glenn M Chertow; Sally Bolus; Matthew D Solomon; Osman S Khawar; Jennifer Talley; Brennan M R Spiegel Journal: Clin J Am Soc Nephrol Date: 2009-04-01 Impact factor: 8.237